Sabuwar allurar rigakafin HPV na iya Rage Ciwon daji na Mahaifa
Wadatacce
Ciwon daji na mahaifa zai iya zama tarihi nan ba da jimawa ba saboda sabon rigakafin cutar HPV da aka yi. Yayin da maganin rigakafi na yanzu, Gardasil, yana ba da kariya daga nau'ikan HPV guda biyu masu haifar da kansa, sabon rigakafin, Gardasil 9, yana kare nau'in HPV guda tara-bakwai waɗanda ke da alhakin yawancin cututtukan sankarar mahaifa. (Likitoci sun ba da shawarar yin allurar HPV a matsayin Alurar A'a 1 Dole Ku Samu don Lafiya Jima'i.)
Binciken da aka buga a bara a Ciwon daji Epidemiology, Biomarkers & Rigakafi ya tabbatar da cewa nau'ikan nau'ikan HPV guda tara waɗanda ke da alhakin kashi 85 ko fiye na raunin da ya faru, kuma sakamakon gwajin allurar rigakafin allurar rigakafin cutar guda tara ya kasance mai matuƙar fa'ida.
Wani sabon binciken a cikin Jaridar New England Journal of Medicine Rahoton Gardasil 9 yana da tasiri daidai da Gardasil wajen hana cututtuka daga nau'ikan nau'ikan 6, 11, 16, da 18, kuma kashi 97 cikin 100 yana da tasiri wajen hana manyan cututtukan mahaifa, vulvar, da farji da ke haifar da ƙarin nau'ikan 31, 33, 45 , 52 da 58.
A cewar mawallafin binciken, Gardasil 9 na iya haɓaka kariyar mahaifa daga kashi 70 na yanzu zuwa kusan kashi 90 cikin 100-kusan kawar da duk waɗannan cututtukan daji a cikin mata masu rigakafin.
FDA ta amince da sabon maganin a watan Disamba kuma yakamata ya kasance ga jama'a a wannan watan. Ana ba da shawarar ga 'yan mata masu shekaru 12-13-kafin su kamu da cutar-amma, a wasu lokuta, yana iya dacewa da mata 24-45. Yi magana da likitan ku don gano idan kun kasance ɗan takara (kuma, yayin da kuke can, bincika idan yakamata ku Ciniki Pap Smear don gwajin HPV).